Journals in Life sciences

Biocatalysis and Agricultural Biotechnology

ISSN: 1878-8181

Official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB)Biocatalysis and Agricultural Biotechnology is the official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB). The journal publishes high quality articles especially in the science and technology of biocatalysis, bioprocesses, agricultural biotechnology, biomedical biotechnology, and, if appropriate, from other related areas of biotechnology. The journal will publish peer-reviewed basic and applied research papers, authoritative reviews, and feature articles.The scope of the journal encompasses the research, industrial, and commercial aspects of biotechnology, including the areas of: biocatalysis; bioprocesses; food and agriculture; genetic engineering; molecular biology; healthcare and pharmaceuticals; biofuels; genomics; nanotechnology; environment and biodiversity; and bioremediation.Types of papers published are: Full-length original research papers; Short communications; Invited reviews; Letters to the Editor.

Subscriptions

Biochemical Engineering Journal

ISSN: 1369-703X

endorsed by Division of Biochemical Engineering, The Society of Chemical Engineers, JapanBiochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit gold open access articles immediately in PubMed Central. For other articles, we shall deposit the accepted manuscript on behalf of the author to PubMed Central after 12 months (the normal embargo period for this journal is 24 months). For more information, please see here.The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturati... Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cellsBioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticalsBioma... and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution*Authors are requested to complete a Review Proposal Form for Editorial approval prior to submission of the review article. Proposals can be submitted to biochemical.engineer... or one of the Editors.

Subscriptions

Biochemical Pharmacology

ISSN: 0006-2952

Biochemical Pharmacology publishes original research findings and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/tran... or drug/compound-induce... modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complementary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.Reports describing experiments conducted with natural product mixtures, plant or animal extracts will not be considered for publication unless the structures and concentrations of all component substances are known, and the agents can be easily obtained by others wishing to replicate the study.The chemical structure of all novel compounds tested must be included in the submitted manuscript or be readily accessible in the published literature. References to structures in the patent literature must unambiguously identify a single molecular structure. All compounds, reagents, instrumentation and equipment employed in a study must be available from identified commercial suppliers, bio/pharmaceutical companies or from individuals holding legal rights to their use. Submissions will not be considered for publication if the chemical structures of tested compounds are not revealed, generally known, or accessible in the literature.Original research submissions must contain:A rationale for the selection of the compound/drug for study as well as for the concentrations/doses employed. Quantities used for concentration- and dose-response experiments should vary logarithmically, e.g., 1, 3, 10, 30 mg/kg, 0.1, 1.0, 10, 100 nanomolar, etc. Justification must be provided for studying only a single concentration or dose of a compound, especially as it relates to reference standards and antagonists/modulato... of receptors, enzymes and signaling pathways.Justificati... must also be provided for the selection of the statistical tests employed as they relate to the experimental design.It is expected that all findings have been subjected to rigorous quantitative analyses, with the calculation and reporting of IC50, Ki, EC50, etc., values. These must be derived from a minimum of three (3) separate and distinct experiments, with the replicates within any single experiment being averaged to obtain a single value for that experimental series.Manuscripts that fail to meet these criteria will be subject to rejection without peer-review.US National Institutes of Health (NIH) voluntary posting ("Public Access") policy:Biochemical Pharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy.

Subscriptions

Biochemical Systematics and Ecology

ISSN: 0305-1978

Biochemical Systematics and Ecology is devoted to the publication of original papers and reviews, both submitted and invited, in two subject areas: I) the application of biochemistry to problems relating to systematic biology of organisms (biochemical systematics); II) the role of biochemistry in interactions between organisms or between an organism and its environment (biochemical ecology).In the Biochemical Systematics subject area, comparative studies of the distribution of (secondary) metabolites within a wider taxon (e.g. genus or family) are welcome. Comparative studies, encompassing multiple accessions of each of the taxa within their distribution are particularly encouraged. Welcome are also studies combining classical chemosystematic studies (such as comparative HPLC-MS or GC-MS investigations) with (macro-) molecular phylogenetic studies. Studies that involve the comparative use of compounds to help differentiate among species such as adulterants or substitutes that illustrate the applied use of chemosystematics are welcome. In contrast, studies solely employing macromolecular phylogenetic techniques (gene sequences, RAPD studies etc.) will be considered out of scope. Discouraged are manuscripts that report known or new compounds from a single source taxon without addressing a systematic hypothesis. Also considered out of scope are studies using outdated and hard to reproduce macromolecular techniques such as RAPDs in combination with standard chemosystematic techniques such as GC-FID and GC-MS.In the Biochemical Ecology subject area, studies addressing the role compounds play in the ecology of the organisms producing them are invited. Moreover, manuscripts that address hypothesis associated with the influence of factors such as altitude, geography, and seasonal variation on the expression of primary and secondary metabolites are encouraged.Research papers should generally represent a complete investigation and not preliminary data. Preliminary reports will only be considered where findings are of sufficient interest to justify rapid publication. New Source Reports will only be considered in cases where a significant chemosystematic or ecological finding is reported. New Source Reports have to be written in a standard format (Example).

Subscriptions

Biochemical and Biophysical Research Communications

ISSN: 0006-291X

Biochemical and Biophysical Research Communications (BBRC) is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. For short communication papers, we offer the fastest submission to acceptance of any journal within life sciences, with "accept" decisions rendered within three weeks of submission. We will now consider full-length research papers and review articles.The journal covers most of areas of life science, and is divided into the following sections: BiochemistryBiophysi... BiologyCellular Pathology and CancerComputational Biology and BioinformaticsGeneti... and InflammationMicrobio... and VirologyNanomedicine and BionanomaterialsNeur... BiologyStructural BiologyPlease see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.Announcement: BBRC has traditionally only published short communications of novel results. From 2023, the journal now publishes short communications, full-length research papers, and reviews.What type of paper should I choose on submission?For short communications, we will still aim to make an accept or reject decision within two weeks of submission. If you have novel results that you can consolidate into 4,600 words, with no more than four figures, then you may continue to choose the short communication route.Short communications should be concise, no more than 4,600 words and up to four display items. They should offer novel insights and warrant a rapid peer review process. The 4,600 word count includes the title page, all sections of the manuscript (including the references), and the figure and table legends. Papers that exceed these limits will be reassigned within the submission system as a full-length research paper.If you submit a full-length research paper or a review paper, we will continue to offer a fast turnaround (with a decision after review within 45–60 days of submission), and we'll also make sure that any revisions that we request of you will not require significant resource expenditure on your part.Full-length research papers should present a comprehensive account of original research. These papers are not restricted by length or number of figures.Review papers should be authoritative, state-of-the-art accounts of the selected research field and be of high interest, balanced, and accurate. Beyond summaries of important scientific developments and ideas, authors are encouraged to identify and discuss how the field may be impacted or develop in the future, including insights that may be of significance to the scientific community. The number of co-authors of review articles is limited to five, and each author is expected to make a substantial contribution to the writing of the manuscript.There are no restrictions on length for review papers, and we welcome both comprehensive reviews and short reviews that offer an insight into more recent advances in a field.

Subscriptions

Biochimica et Biophysica Acta: Bioenergetics

ISSN: 0005-2728

BBA Bioenergetics covers the area of biological membranes involved in energy transfer and conversion. In particular, it focuses on elucidating molecular mechanisms and structure-function relationships of bioenergetic components of photosynthesis, mitochondrial and bacterial respiration, oxidative phosphorylation, and motility and transport, as well as their structural aspects. The journal spans applications of advanced biochemical and biophysical approaches, including spectroscopy, structural biology, and molecular modeling in these systems. Additionally, it addresses bioenergetic aspects of mitochondrial biology, including biomedical aspects of energy metabolism, also related to mitochondrial disorders and neurodegenerative diseases.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.

Subscriptions

Biochimica et Biophysica Acta: Biomembranes

ISSN: 0005-2736

BBA Biomembranes has its main focus on membrane structure, function and biomolecular organization, membrane proteins, receptors, channels and anchors, fluidity and composition, model membranes and liposomes, membrane surface studies and ligand interactions, transport studies, and membrane dynamics.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Biochimica et Biophysica Acta: Gene Regulatory Mechanisms

ISSN: 1874-9399

BBA Gene Regulatory Mechanisms includes reports that describe novel insights into mechanisms of transcriptional, post-transcriptional and translational gene regulation. Special emphasis is placed on papers that identify epigenetic mechanisms of gene regulation, including chromatin, modification, and remodeling. This section also encompasses mechanistic studies of regulatory proteins and protein complexes; regulatory or mechanistic aspects of RNA processing; regulation of expression by small RNAs; genomic analysis of gene expression patterns; and modeling of gene regulatory pathways. Papers describing gene promoters, enhancers, silencers or other regulatory DNA regions must incorporate significant functions studies.The journal does not favorably review manuscripts identifying a miRNA-target pair without additional insights into the repression mechanism or significant advances in understanding regulatory pathways. In addition, the following elements should be an integral part of the study: •In silico prediction of miRNA targets must be experimentally verified using appropriate luciferase constructs and assays; •To exclude non-functional miRNA/mRNA interactions a reporter system including the whole 3'UTR of the target gene downstream the "luciferase" or GFP should be considered; •Any miRNA modulation should be validated by measuring the expression of the putative proteinPlease see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Biochimica et Biophysica Acta: General Subjects

ISSN: 0304-4165

BBA General Subjects invites submissions of original research, hypothesis-driven studies, and reviews that address topics in biochemistry and biophysics. Manuscripts should present significant advancements in our understanding of molecular mechanisms and be of broad scientific interest to a wide audience. Interdisciplinary studies are encouraged. Descriptive studies without biochemical or biophysical mechanistic evidence and insights are discouraged. Preferred topics areBiomedicine: Fundamental and emerging topics in biochemistry/biophys... with potential medical implicationsNanobiol... Nanoparticles, nanotoxicology, nanomedicine; the topics are not limited to formulation of nanoparticles but investigate mechanism of action on cell types or animal models.Omics: Genomics, proteomics, lipidomics, glycomics, bioinformatics experimentally addressing a defined biological question; descriptive bioinformatics studies that rely solely on publicly available data without experimental validation are discouraged.Chemical biology: Chemical compounds, drug mechanisms, synthesis of novel compounds, click chemistryStructural biology: Crystallography, NMR, multimeric proteins, protein dynamics, nucleic acidsNovel complexes: Nucleic acids, pure natural compounds, synthetic compounds, protein complexes, nucleic acid derivativesCellular signaling: Receptor signaling, protein phosphorylation cascades, phosphatases, secondary messengers, transcription regulation, gene expressionGlycobiolo... Sugar metabolites and metabolism, glycosylated proteins, membrane protein, glycosylation, glycomicsMicrobiolog... Fundamental and applied microbiology, emphasizing biochemical and biophysical aspects and mechanistic insights into infection and disease, as well as the mechanism of action of antimicrobials; manuscripts on clinical aspects such as treatment outcomes, clinical trials, and patient management are not suitable for this journal. Redox biology: Redox switches, glutathione and thioredoxin systems, oxygen and nitrogen radical species, superoxide, hydrogen peroxide, hydroxyl radical, nitric oxide, peroxides, hypoxia, redox regulation of transcription factorsNeurobiology: Neuronal growth factors and nerve signaling, glial cells, autonomic and central nervous systemsStem cells: Differentiation, stem cell isolation and cultivation, growth factorsAdvanced molecular imaging technologies: This may include both biochemical and biophysical approaches.Plant biology: Specific emphasis on molecular plant sciences with mechanistic details and their applications through plant biotechnologyMechani... characterization of compounds having biochemical importance and general interest (drug leads, toxicants, nutrients, and metabolites)BBA General Subjects does not consider studies on the biological effects of crude extracts of natural sources, natural extracts, or traditional medicine unless the exact active molecules are identified and singularly characterized and their mechanism of action is experimentally evaluated.

Subscriptions

Biochimica et Biophysica Acta: Molecular Basis of Disease

ISSN: 0925-4439

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiov... diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunologica... diseasesInflammatory diseasesMetabolic diseasesMitochondria... diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computation... (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descripti... or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparati... Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.

Subscriptions

Related subjects

Agricultural and biological sciences

Drug discovery

Immunology

Microbiology and virology

Neuroscience

Pharmaceutical sciences

Pharmacology

Toxicology

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Life sciences

Biocatalysis and Agricultural Biotechnology

Biochemical Engineering Journal

Biochemical Pharmacology

Biochemical Systematics and Ecology

Biochemical and Biophysical Research Communications

Biochimica et Biophysica Acta: Bioenergetics

Biochimica et Biophysica Acta: Biomembranes

Biochimica et Biophysica Acta: Gene Regulatory Mechanisms

Biochimica et Biophysica Acta: General Subjects

Biochimica et Biophysica Acta: Molecular Basis of Disease

Related subjects